Last reviewed · How we verify
NCT04034875
Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.
NA trial testing Questionnaire in Cerebral Lesion in 50 participants. Completed in 28 July 2023.
28 July 2023
Quick facts
| Lead sponsor | Brugmann University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 50 |
| Start date | 9 April 2019 |
| Primary completion | 28 July 2023 |
| Estimated completion | 28 July 2023 |
| Sites | 3 locations across Belgium, France |
Drugs / interventions tested
- Questionnaire
Conditions studied
- Cerebral Lesion — all drugs for Cerebral Lesion →
Sponsor
Brugmann University Hospital
Who can join
Adults 18 to 75, any sex, with Cerebral Lesion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described. These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression. It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French. The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model. The development of such a tool will be of major interest for clinical practice and future clinical research.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04034875
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire
Trials testing the same drug.
- NCT04466371 — Perceptions of Undergraduate Students and Teaching Staff on Online Teaching · suspended
- NCT07089953 — Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomiz · NA · not yet recruiting
- NCT07418775 — Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma · not yet recruiting
- NCT07226804 — Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules · not yet recruiting
- NCT07532954 — The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support · recruiting
Other recruiting trials for Cerebral Lesion
Currently open trials in the same condition.
- NCT05922748 — Brain Injury and Cognitive Function · NA · recruiting
Other Brugmann University Hospital trials
Trials by the same sponsor.
- NCT07267403 — Comparison of Modulations of Motor Brain Activity and SedLine After Median Nerve Stimulation in General Anesthesia · NA · recruiting
- NCT07267416 — Impact of Combined PSi + NIRS Monitoring in the Prevention of Postoperative Cognitive Disorders in Cardiac Surgery. · NA · recruiting
- NCT07413315 — Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate. · NA · recruiting
- NCT06292377 — Better Understanding of Fatigue After STroke · NA · recruiting
- NCT06160232 — Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04034875 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brugmann University Hospital
- Last refreshed: 9 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04034875.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing